Detalles de la búsqueda
1.
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
Antimicrob Agents Chemother
; 68(4): e0156223, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376228
2.
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis.
Antimicrob Agents Chemother
; 67(12): e0078923, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966090
3.
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
Antimicrob Agents Chemother
; 67(4): e0003523, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920217
4.
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Antimicrob Agents Chemother
; 66(6): e0013222, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35607978
5.
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33526488
6.
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833432
7.
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28630203
8.
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 60(8): 4590-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27185800
9.
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother
; 60(1): 270-7, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503656
10.
Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis.
Antimicrob Agents Chemother
; 59(1): 129-35, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25331697
11.
A systematic efficacy analysis of tuberculosis treatment with BPaL-containing regimens using a multiscale modeling approach.
CPT Pharmacometrics Syst Pharmacol
; 13(4): 673-685, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38404200
12.
Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
Antimicrob Agents Chemother
; 57(8): 3910-6, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23733473
13.
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Antimicrob Agents Chemother
; 56(6): 3114-20, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22470112
14.
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Antimicrob Agents Chemother
; 56(8): 4331-40, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22664964
15.
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Antimicrob Agents Chemother
; 56(7): 3726-31, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22547623
16.
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Antimicrob Agents Chemother
; 55(4): 1781-3, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282421
17.
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Antimicrob Agents Chemother
; 55(12): 5485-92, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21930883
18.
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens.
Nat Commun
; 12(1): 2899, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006838
19.
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".
Antimicrob Agents Chemother
; 57(2): 1104-5, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23341430
20.
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
PLoS One
; 13(5): e0196815, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29718990